Diabetes mellitus, type 2 Trials in Los Angeles, United States
Conditions / Diabetes mellitus, type 2 / Los Angeles, United States
Diabetes mellitus, type 2 is a medical condition with active clinical research programs worldwide.
177 total trials for this combination
Showing top 10 of 177 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00968708 | Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome | COMPLETED | PHASE3 |
| NCT02487888 | A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient Care | UNKNOWN | NA |
| NCT05649137 | A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight | COMPLETED | — |
| NCT02065791 | Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy | COMPLETED | PHASE3 |
| NCT01991795 | A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT01042769 | A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus | COMPLETED | PHASE3 |
| NCT06267391 | Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes | RECRUITING | NA |
| NCT01179048 | Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results | COMPLETED | PHASE3 |
| NCT01336023 | Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT05514535 | A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE) | COMPLETED | PHASE3 |